GlassScriptPhysician profile
Philip Alian
NPI 1023527975
$5,158.76
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,997 · 2022: $2,167 · 2023: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $980 · Education: $14.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $979.86 |
| Education | $14.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,075.80 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,119.05 | 2021-2023 | Trulance, Xifaxan |
| Janssen Biotech, INC. | $451.89 | 2022-2023 | Stelara, Simponi, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $328.85 | 2021-2023 | Entyvio |
| Redhill Biopharma INC. | $307.21 | 2021-2022 | |
| Qol Medical, LLC | $201.56 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $128.46 | 2022-2023 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 2022 | |
| Incyte Corporation | $115.00 | 2021 | |
| Genzyme Corporation | $63.20 | 2022 | |
| Braintree Laboratories, INC. | $61.63 | 2021-2022 | |
| Pfizer INC. | $33.07 | 2022-2023 | |
| Intercept Pharmaceuticals, INC. | $31.96 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $29.47 | 2022 | |
| Amgen INC. | $25.32 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $21.40 | 2022 | |
| Ferring Pharmaceuticals INC. | $21.39 | 2023 | Rebyota |
| Nestle Healthcare Nutrition INC. | $18.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Alian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.